Latest news

Insights

Why Every Pharma Company Needs a Unified Data Platform

Pharma Company:Executive Summary Pharmaceutical companies have never had more data. Research organizations generate molecular and genomic information. Clinical teams produce trial...
Insights

AI-Powered Pharma Customer Engagement

Executive Summary Pharmaceutical customer engagement is undergoing a fundamental shift. Healthcare professionals (HCPs) are exposed to growing volumes of scientific information,...
Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for its influenza vaccine, giving the French biotech an opportunity to...
Clinical

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

AstraZeneca and Amgen's anti-inflammatory therapy, Tezspire, which has been approved for asthma and chronic rhinosinusitis, met both of its...
Insights

Top 10 Digital Risks Facing Biotech Companies

Executive Summary Biotechnology companies are becoming increasingly dependent on digital...
Insights

AI in GMP Compliance

Executive Summary Good Manufacturing Practice (GMP) compliance is becoming increasingly...
Insights

The Future of Global Drug Regulation

Executive Summary Drug regulation is entering a period of significant transformation. For decades, pharmaceutical regulation has relied on established scientific standards,...
Insights

Why Pharmaceutical Companies Need AI Factories

Executive Summary Artificial intelligence is moving from experimentation to infrastructure. Pharmaceutical companies have spent the past several years testing AI across...
Regulatory

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

Key Trial Breakthrough in Skin Cancer The personalized mRNA cancer vaccine developed by Merck & Co. and Moderna has proven...
Regulatory

FDA Issues Warning Letters to Aurobindo’s Eugia Unit and Tianjin Kilo Pharmaceutical

The U.S. Food and Drug Administration (FDA) has issued...
Research & Development

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Novo Nordisk has started a new late-stage clinical study...
Insights

Quantum Computing and Drug Discovery

Executive Summary Pharmaceutical drug discovery is fundamentally a problem of understanding molecules. Researchers need to determine how compounds interact with biological...
Regulatory

After a GLP-1 inhibitor lowers blood sugar crashes in a Ph. 3 victory, Amylyx prepares to push for approval

A $35 Million GLP-1 Bet Pays Off It looks like Amylyx Pharmaceuticals' $35 million gamble on the GLP-1 receptor agonist...
Clinical

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Biokin Pharma reported positive results from the phase 3 Panku-Lung01 study of iza-bren, its EGFRxHER3 bispecific antibody-drug conjugate (ADC)...
Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for...
Editorial Team -
Commercial

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

Leo Pharma is continuing its push to expand its...
Editorial Team -
Commercial

Alcon’s Strategic Move: AR-15512 Breakthrough in Dry Eye Treatment

Alcon's recent acquisition of Aerie Pharmaceuticals for $770 million...
Commercial

Incyte’s $750M Acquisition Shaken by Key Trial Pause and Asset Cuts

Incyte faced severe difficulties just a few months after...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for...
Editorial Team -
Insights

AI-Powered Pharma Customer Engagement

Executive Summary Pharmaceutical customer engagement is undergoing a fundamental shift. Healthcare...
Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for...
Clinical

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

AstraZeneca and Amgen's anti-inflammatory therapy, Tezspire, which has been...
Clinical

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Bausch + Lomb had an investigational eye drop that...

Research & Development

Market Access

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Why Every Pharma Company Needs a Unified Data Platform

Pharma Company:Executive Summary Pharmaceutical companies have never had more data. Research...
Editorial Team -
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Editorial Team -
Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for...
Editorial Team -